Cargando…
Executive Summary of the 2020 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines
Dyslipidemia is a cardiovascular risk factor that is increasing in prevalence in the country. The need to treat and manage elevated cholesterol levels, both pharmacologic and non-pharmacologic, is of utmost importance. Different medical societies and groups bonded together to formulate the 2020 Phil...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of the ASEAN Federation of Endocrine Societies
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214350/ https://www.ncbi.nlm.nih.gov/pubmed/34177082 http://dx.doi.org/10.15605/jafes.036.01.01 |